Use of epigenetically modified bacteriophage and dual beta-lactams to treat a Mycobacterium abscessus sternal wound infectionMadison Cristinziano, Anne Friedland, Leonard J. Lobo et al.|Nature Communications|2024Cited by 22
Use of epigenetically modified bacteriophage and dual beta-lactams to treat a Mycobacterium abscessus sternal wound infectionRebecca A. Garlena, Christina T. Doligalski, Deborah Jacobs‐Sera et al.|UNC Libraries|2024Cited by 0
P-1874. Impact of Compromised Host AntimicRobial Management Service (CHARMS) on All Cause Readmission in Solid Organ Transplant Patients Discharged on Intravenous AntimicrobialsBrent Footer, David van Duin, Luther A. Bartelt et al.|Open Forum Infectious Diseases|2025Cited by 0